- Home
- MSTR vs MDT Comparison
MSTR vs MDT Comparison
Compare MSTR & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSTR
- MDT
- Stock Information
- Founded
- MSTR 1989
- MDT 1949
- Country
- MSTR United States
- MDT Ireland
- Employees
- MSTR N/A
- MDT N/A
- Industry
- MSTR Computer Software: Prepackaged Software
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MSTR Technology
- MDT Health Care
- Exchange
- MSTR Nasdaq
- MDT Nasdaq
- Market Cap
- MSTR 109.3B
- MDT 112.1B
- IPO Year
- MSTR 1998
- MDT N/A
- Fundamental
- Price
- MSTR $369.70
- MDT $86.34
- Analyst Decision
- MSTR Strong Buy
- MDT Buy
- Analyst Count
- MSTR 11
- MDT 15
- Target Price
- MSTR $404.18
- MDT $98.00
- AVG Volume (30 Days)
- MSTR 10.7M
- MDT 8.3M
- Earning Date
- MSTR 07-31-2025
- MDT 05-21-2025
- Dividend Yield
- MSTR N/A
- MDT 3.29%
- EPS Growth
- MSTR N/A
- MDT 30.80
- EPS
- MSTR N/A
- MDT 3.61
- Revenue
- MSTR $459,276,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- MSTR $1.91
- MDT $6.31
- Revenue Next Year
- MSTR $3.40
- MDT $5.27
- P/E Ratio
- MSTR N/A
- MDT $23.88
- Revenue Growth
- MSTR N/A
- MDT 3.62
- 52 Week Low
- MSTR $102.40
- MDT $75.96
- 52 Week High
- MSTR $543.00
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- MSTR 45.51
- MDT 52.60
- Support Level
- MSTR $367.00
- MDT $85.41
- Resistance Level
- MSTR $388.15
- MDT $88.77
- Average True Range (ATR)
- MSTR 13.16
- MDT 1.28
- MACD
- MSTR -2.45
- MDT 0.01
- Stochastic Oscillator
- MSTR 17.71
- MDT 62.96
About MSTR MicroStrategy Incorporated
Strategy is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provide industry AI-powered enterprise analytics software.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.